Patients With More Severe PH in COPD May Respond to Treatment medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
MedAlliance has announced completion of patient enrolment in the PRISTINE clinical trial with SELUTION SLRamp;trade;018 DEB (drug-eluting balloon) for the treatmen
NYON, Switzerland, Aug. 13, 2021 /PRNewswire/ MedAlliance has announced completion of patient enrolment in the PRISTINE clinical trial with SELUTION SLR 018 DEB (drug-eluting balloon) for
AMSTAR 2 is a common instrument to evaluate the methodology of SRs.
18 Two researchers (LPY/DLZ) independently assessed the methodology of SRs using AMSTAR2. AMSTAR2 has 16 items, including seven critical items (item 2/4/7/9/11/13/15) which can critically affect the validity of a SR and its conclusion. Each item was evaluated as “yes,” “partial yes,” and “no” according to the standard of AMSTAR 2 guideline.
18 The details of AMSTAR 2 items and the general rules for results of a SR are seen in
Appendix B. Discrepancies were solved by team discussion.
Assessment of Risk of Bias
ROBIS is a tool designed specifically to assess the risk of bias in SRs,